www.fastcompany.com
1 week agoBig Pharma is losing its fight to avoid prescription drug price negotiations
The federal court rejected AstraZeneca's claim on prescription drug price negotiations under the 2022 IRA.
The ruling impacts 10 Medicare Part D-covered prescriptions and aims to set fair prices for these drugs.